Why are oral weight-loss drugs a new target for counterfeiters?

Oral weight-loss drugs, like pills, are easier for criminals to manufacture and distribute compared to injectable medications, which require more specialized equipment.

What risks do counterfeit weight-loss pills pose?

Counterfeit pills may be contaminated, contain incorrect dosages, or lack any active ingredients, posing significant risks to public health.

What is being done to combat fake weight-loss treatments?

Regulatory bodies are working to combat falsified medicines, pharmaceutical companies are monitoring online sales, and public health campaigns are advised.

Home / Health / Fake Weight-Loss Pills Flood Market?

Fake Weight-Loss Pills Flood Market?

24 Jan

•

Summary

Oral weight-loss treatments pose new risks for counterfeiters.
Pills are easier to fake than injectable medications.
Stronger regulation is needed to combat fraud.

The upcoming launch of oral weight-loss medications, including tablet forms of Wegovy and Mounjaro, is expected to increase the prevalence of counterfeit treatments. Experts highlight that pills are far easier for fraudsters to produce than injectable medications, requiring less specialized equipment and allowing for larger-scale production. This ease of counterfeiting poses a significant risk, as fake pills could be contaminated, contain incorrect dosages, or lack active ingredients entirely.

Regulatory bodies like the MHRA are actively working to combat falsified medicines, having recently seized over £250,000 worth of counterfeit weight-loss injections. However, the increased accessibility and lower cost of oral medications are anticipated to stretch enforcement resources, potentially enabling counterfeit products to enter the market more easily. Pharmaceutical companies are implementing strategies, including online monitoring and collaboration with authorities, to combat these illicit operations. Public health campaigns and robust verification systems for online pharmacies are also recommended to mitigate risks.